RA
Raia Drogasil S.A.
RADL3.SA · SAO
R$ 19.57 +0.05% (+R$ 0.01)
1M +13.26%
Market Cap R$ 35.4B
P/E Ratio 26.36x
Div. Yield 0.78%
ROE 18.55%
Bulios Fair Price
R$ 19.49
0.4% downside
Trenutna cena
R$ 19.57
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica RADL3.SA trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
62 /100
Fair P/FCF 21.73x
P/S 0.79x
P/B 4.85x
Growth
82 /100
Growing Rev. growth 15.04%
FCF growth 27.70%
Book val. growth 11.09%
Profitability
32 /100
Weak Net margin 2.98%
Op. margin 6.52%
FCF margin 3.62%
Quality
82 /100
Excellent ROE 18.55%
ROA 5.34%
Asset turnover 1.79x
Debt
54 /100
Moderate Current ratio 1.41x
Int. coverage 2.41x
Net debt/EBITDA 1.64x
Stability
75 /100
Stable Rev. volatility 1.61%
EPS volatility 7.51%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RADL3.SA
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Renato Raduan
Employees
75,594
Headquarters
São Paulo
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report